Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome

Background:Colon cancer predisposition is associated with mutations in BRCA1. BRCA1 protein stability depends on binding to BARD1. In different cancers, expression of differentially spliced BARD1 isoforms is correlated with poor prognosis and decreased patient survival. We therefore suspected a role of BARD1 isoforms in colon cancer.Methods:We performed immunohistochemistry in 168 colorectal cancers, using four antibodies directed against differentially expressed regions of BARD1. We determined structure and relative expression of BARD1 mRNA isoforms in 40 tumour and paired normal peri-tumour tissues. BARD1 expression was correlated with clinical outcome.Results:BARD1 isoforms were expressed in 98% of cases and not correlated with BRCA1. BARD1 mRNA isoforms were upregulated in all tumours as compared with paired normal peri-tumour tissues. Non-correlated expression and localisation of different epitopes suggested insignificant expression of full-length (FL) BARD1. Expression of N- and C-terminal epitopes correlated with increased survival, but expression of epitopes mapping to the middle of BARD1 correlated with decreased survival. Middle epitopes are present in oncogenic BARD1 isoforms, which have pro-proliferative functions. Correlated upregulation of only N- and C-terminal epitopes reflects the expression of isoforms BARD1δ and BARD1ϕ.Conclusion:Our results suggest that BARD1 isoforms, but not FL BARD1, are expressed in colon cancer and affect its progression and clinical outcome.

• Publication year

  2012

• Venue

  British Journal of Cancer

• Publication date

  2012-07-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.2012.297PMID 22814582PMCID 3419952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BARD1: An independent predictor of survival in non‐small cell lung cancer

  2012influential reference
• Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

  2012cited by this paper
• BARD1 Expression Predicts Outcome in Colon Cancer

  2011influential reference
• Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.

  2010cited by this paper
• BRCA1 mutations and colorectal cancer in Poland

  2010cited by this paper
• Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.

  2009cited by this paper
• Molecular origins of cancer: Molecular basis of colorectal cancer.

  2009cited by this paper
• Hereditary ovarian cancer.

  2009cited by this paper
• Estrogen and its role in gastrointestinal health and disease

  2009cited by this paper
• Counseling for male BRCA mutation carriers: a review.

  2008cited by this paper
• Adjuvant therapy for completely resected stage II colon cancer.

  2008cited by this paper
• Oncogenic BARD1 isoforms expressed in gynecological cancers.

  2007cited by this paper
• Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations

  2007cited by this paper
• Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

  2007cited by this paper
• Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis

  2006influential reference
• Is there more to BARD1 than BRCA1?

  2006cited by this paper
• The connection between splicing and cancer

  2006cited by this paper
• Molecular mechanisms of hepatic metastasis in colorectal cancer

  2005cited by this paper
• BRCA1 Phosphorylation by Aurora-A in the Regulation of G2 to M Transition*

  2004cited by this paper
• BRCA1-Dependent Ubiquitination of γ-Tubulin Regulates Centrosome Number

  2004cited by this paper
• Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer.

  2004cited by this paper
• BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.

  2004cited by this paper
• BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer.

  2004influential reference
• BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

  2004cited by this paper
• Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas.

  2003cited by this paper
• Targeted substrate degradation by an engineered double RING ubiquitin ligase.

  2002cited by this paper
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

  2002cited by this paper
• The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

  2002cited by this paper
• BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export*

  2002cited by this paper
• DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.

  2001cited by this paper
• Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1

  2001cited by this paper
• Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Identification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies.

  2000cited by this paper
• Mapping the Functional Domains of BRCA1

  1999cited by this paper
• Colorectal cancer in hereditary breast cancer kindreds

  1999cited by this paper
• Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer.

  1998cited by this paper
• A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

  1998cited by this paper
• In Vitro Repression of Brca1-associated RING Domain Gene, Bard1, Induces Phenotypic Changes in Mammary Epithelial Cells

  1998cited by this paper
• Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Unusual case of Smith-Lemli-Opitz syndrome "type II".

  1995cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper

• BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?

  2025cites this paper
• Isoform alterations in the ubiquitination machinery impacting gastrointestinal malignancies

  2024cites this paper
• Functional Analysis of BARD1 Missense Variants on Homology‐Directed Repair in Ovarian and Breast Cancers

  2024cites this paper
• Germline heterozygous exons 8–11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?

  2023cites this paper
• Targeted splicing therapy: new strategies for colorectal cancer

  2023cites this paper
• Zooming into the structure-function of RING finger proteins for anti-cancer therapeutic applications.

  2023cites this paper
• HuR Plays a Role in Double-Strand Break Repair in Pancreatic Cancer Cells and Regulates Functional BRCA1-Associated-Ring-Domain-1(BARD1) Isoforms

  2022cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Establishment and verification of a prognostic model of liver cancer by RNA-binding proteins based on the TCGA database

  2021cites this paper
• BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer

  2021cites this paper
• Expression of BARD1 β Isoform in Selected Pediatric Tumors

  2021cites this paper
• SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells

  2020cites this paper
• The Function of BARD1 in Centrosome Regulation in Cooperation with BRCA1/OLA1/RACK1

  2020cites this paper
• Novel urinary protein biomarker panel for early diagnosis of gastric cancer

  2020cites this paper
• SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells

  2020cites this paper
• The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers

  2020cites this paper
• MicroRNA Assisted Gene Regulation in Colorectal Cancer

  2019cites this paper
• Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification

  2019cites this paper
• DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications.

  2018cites this paper
• Key genes and regulatory networks involved in the initiation, progression and invasion of colorectal cancer

  2018cites this paper
• Genetic susceptibility to neuroblastoma: current knowledge and future directions

  2018influential citation
• Genetic susceptibility to neuroblastoma: current knowledge and future directions

  2018influential citation
• BARD1 serum autoantibodies for the detection of lung cancer

  2017cites this paper
• New concepts on BARD1: Regulator of BRCA pathways and beyond.

  2016cites this paper
• Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability

  2016cites this paper
• Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer

  2016cites this paper
• Nanopore Sequencing of RNA from Breast Cancer Genes

  2016influential citation
• BARD1 mediates TGF-β signaling in pulmonary fibrosis

  2015cites this paper
• BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression

  2015cites this paper
• Association of three common BARD1 variants with cancer susceptibility: a system review and meta-analysis.

  2015cites this paper
• Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.

  2015cites this paper
• Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.

  2015cites this paper
• Cancer predisposing BARD 1 mutations affect exon skipping and are associated with overexpression of specific BARD 1 isoforms

  2015cites this paper
• Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.

  2014cites this paper
• Assessment of DNA-damage repair in breast cancer

  2014cites this paper
• Alternative splicing in cancer: implications for biology and therapy

  2014cites this paper
• Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1

  2014cites this paper
• Identification of MET genomic amplification, protein expression and alternative splice isoforms in neuroblastomas

  2013cites this paper
• A Cross-Sectional Study of Associations Between Nonsynonymous Mutations of the BARD1 Gene and Breast Cancer in Han Chinese Women

  2013cites this paper